Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
50 studies found for:    "Hyperparathyroidism primary"
Show Display Options
Rank Status Study
21 Completed Open Versus Video-Assisted Minimal-Invasive Parathyroid Surgery
Condition: Primary Hyperparathyroidism
Intervention: Procedure: Minimal invasive Parathyroid surgery
22 Completed An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism
Conditions: Parathyroid Carcinoma;   Hypercalcemia;   Primary Hyperparathyroidism
Intervention: Drug: Cinacalcet HCl
23 Completed Radius Loading in Primary Hyperparathyroidism
Conditions: Primary Hyperparathyroidism;   Bone Diseases, Metabolic;   Osteoporosis, Postmenopausal;   Bone Loss, Postmenopausal
Interventions: Other: Forearm exercise program;   Other: Walking program
24 Withdrawn Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D
Conditions: Primary Hyperparathyroidism;   Hypercalcemia;   Vitamin D Deficiency;   Osteoporosis;   Osteopenia
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Vitamin D3
25 Completed A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer
Conditions: Hyperparathyroidism;   Parathyroid Neoplasms
Intervention: Drug: AMG 073
26 Recruiting Preliminary Study Concerning the Validity of Parathyroid Exploration on a CZT Camera
Condition: Primary Hyperparathyroidism
Intervention: Device: Tomoscintigraphic parathyroid imaging on a CZT camera
27 Recruiting 11C Methionine PET for the Detection of Hyperfunctional Parathyroid Tissues
Condition: Primary Hyperparathyroidism
Interventions: Radiation: 11C-Methionine PET/CT scanning;   Radiation: 18F-FDG PET/CT scanning;   Radiation: SPECT-CT scanning
28 Completed Near Infrared Fluorescent Imaging in Thyroid and Parathyroid Surgery With the Fluobeam(TM) System of Fluoptics
Condition: Primary Hyperparathyroidism
Intervention: Device: Fluobeam(TM) Imaging System (Fluoptics)
29 Recruiting Minimally Invasive Radioguided Parathyroidectomy
Condition: Primary Hyperparathyroidism
Intervention: Other: Minimally invasive radioguided parathyroidectomy
30 Completed The Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid Registry
Condition: Primary Hyperparathyroidism
Intervention:
31 Completed
Has Results
Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy
Conditions: Hyperparathyroidism, Primary;   Hypercalcemia
Interventions: Drug: Cinacalcet;   Drug: Placebo
32 Completed Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism
Conditions: Hyperparathyroidism, Primary;   Osteoporosis
Interventions: Drug: cinacalcet;   Drug: Alendronate
33 Withdrawn The Effects of Alendronate After Cure of Primary Hyperparathyroidism
Condition: Hyperparathyroidism
Intervention: Drug: Alendronate 70mg weekly
34 Active, not recruiting Effects of Vitamin D Replacement in Patients With Primary Hyperparathyroidism (PHPT)
Condition: Hyperparathyroidism
Interventions: Drug: Vitamin D;   Device: Four-dimensional computed tomography (4DCT)
35 Recruiting Insulin Resistance in Primary Hyperparathyroidism
Conditions: Hyperparathyroidism;   Diabetes;   Hypercalcemia
Intervention: Procedure: parathyroidectomy
36 Unknown  Differentially Expressed Proteins in Sporadic Parathyroid Tumors
Conditions: Primary Hyperparathyroidism;   Hypercalcemia
Intervention:
37 Withdrawn Multicenter Registry Comparing Preoperative Imaging for Primary Hyperparathyroidism
Condition: Parathyroid Adenoma
Intervention:
38 Completed Oral Peptones Load in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism and Healthy Subjects
Conditions: Hyperparathyroidism;   Hypercalcemia
Intervention: Other: Oral peptones load
39 Completed A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism
Condition: Hyperparathyroidism, Primary
Intervention: Drug: cinacalcet
40 Completed A Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT)
Condition: Hyperparathyroidism, Primary
Interventions: Drug: placebo;   Drug: cinacalcet

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-50) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.